🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as paclitaxel and carboplatin, ...
Status
Completed
Location
Instituto Alexander Fleming
Start Date
2005-11-03
Trial ID
NCT00245154
Treatments Being Tested
Cediranib is being tested to assess its effectiveness on the growth of kidn...
Status
Completed
Location
Research Site
Start Date
2007-01
Trial ID
NCT00423332
Treatments Being Tested
The purpose of this study is to determine whether AZD2171 can effectively i...
Status
Completed
Location
Research Site
Start Date
2007-03
Trial ID
NCT00454805
Treatments Being Tested
The purpose of this study is to see how effective cediranib is in treating ...
Status
Completed
Location
Research Site
Start Date
2008-10
Trial ID
NCT00777153
Treatments Being Tested
The purpose of this study is to assess the safety and efficacy of cediranib...
Status
Unknown
Location
University College London
Start Date
2007-07
Trial ID
NCT00532194
Treatments Being Tested
COMICE is a randomised, double blind placebo controlled Phase II trial. The...
Status
Active Not Recruiting
Location
Clatterbridge Cancer Centre
Start Date
2018-10-09
Trial ID
NCT04487587
Treatments Being Tested
This randomized phase I/II trial is studying the side effects and best dose...
Status
Active Not Recruiting
Location
Highlands Oncology Group - Rogers
Start Date
2010-03-15
Trial ID
NCT01064648
RATIONALE: Cediranib Maleate and gefitinib may stop the growth of tumor cel...
Status
Terminated
Location
University College Hospital
Start Date
2011-05
Trial ID
NCT01310855
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as carboplatin and paclitaxel, ...
Status
Completed
Location
Leicester Royal Infirmary
Start Date
2010-06
Trial ID
NCT01229930
The purpose of this study is to determine if Cediranib when added to chemot...
Status
Completed
Location
Research Site
Start Date
2006-11
Trial ID
NCT00399035